FDAFDA · Food and drugs·Recall number D-1069-2019
Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017. NDC 0009-3447-01
Published April 10, 2019 · Recall initiated: March 15, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CLEOCIN PHOSPHATE
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide USA and Guam
- Lot
- Lot #: T78193, Exp.04/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.